[DOI] [PMC free article] [PubMed] [Google Scholar] 40.Sharretts J, Galescu O, Gomatam S
Investigational glucagon receptor antagonists in phase I and II clinical trials for diabetes
It is primarily used to treat vitamin B12 deficiency, which can lead to anemia, fatigue, and neurological symptoms
At the end of Part 1, participants who met eligibility criteria (at least 15% weight loss at week 52 and still taking investigational product) had the option to enter Part 2 of the study
Other studies have shown that quercetin has prevented cell death in the PD mice research model, however, when quercetin is used as its metabolite known as quercetin-3-O--glucuronide due to its lower absorption rate (Muoz-Reyes et al., 2022)
Amaglo NK, Bennett RN, Curto RB, Rosa EA, Turco VL, Giuffrida A, Curto AL, Crea F, Timpo GM